TrialBMC endocrine disorders2025

Effect of empagliflozin on liver fibrosis and steatosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: a randomized clinical trial.

Azam Erfanifar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.